Virtus Alternative Investment Advisers’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-173
Closed -$7K 125
2020
Q4
$7K Sell
173
-167
-49% -$5.97K 0.1% 130
2020
Q3
$11K Sell
340
-144
-30% -$4.32K 0.2% 165
2020
Q2
$13K Sell
484
-454
-48% -$11.9K 0.2% 201
2020
Q1
$23K Buy
938
+684
+269% +$21.1K 0.32% 56
2019
Q4
$9K Buy
+254
New +$8.77K 0.14% 140

Other funds holding LMAT

Virtus Alternative Investment Advisers's LMAT Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of LeMaitre Vascular (LMAT) in Q1 2021, closing a stake of 173 shares — an estimated $7K sold.

Virtus Alternative Investment Advisers first reported a position in LMAT in Q4 2019 and held it in 5 quarters. The position peaked at $23K in Q1 2020. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining LeMaitre Vascular position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 173 LeMaitre Vascular shares in Q1 2021, an estimated $7K.
  • Virtus Alternative Investment Advisers first reported a position in LeMaitre Vascular in Q4 2019 and held it in 5 quarters.
  • Virtus Alternative Investment Advisers's LeMaitre Vascular position peaked at $23K in Q1 2020.
  • 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.